Literature DB >> 8346278

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

S Webb1, A E Nahum.   

Abstract

Most calculations of the biological effect of radiation on tumours assume that the clonogenic cell density is uniform even if account is taken of non-uniform dose distribution. In practice tumours will almost certainly have a non-uniform clonogenic cell density. This paper extends one particular model of tumour control probability (TCP) to incorporate a variable clonogenic cell density while at the same time assuming a constant 2 Gy fraction size and a uniform radiosensitivity throughout the treatment. Since there are virtually no in vivo data on the variation of density we consider some model situations. One clear conclusion is that a large reduction in clonogenic cell density at the edges of a tumour would permit only a very modest decrease in dose if the TCP is not to be reduced. In general the effect on TCP is a complicated function of the variation in both dose and clonogenic cell density. We give the equations which enable both to be included.

Entities:  

Mesh:

Year:  1993        PMID: 8346278     DOI: 10.1088/0031-9155/38/6/001

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  80 in total

1.  On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy.

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Imaging Decis (Berl)       Date:  2008

2.  A graphic user interface toolkit for specification, report and comparison of dose-response relations and treatment plans using the biologically effective uniform dose.

Authors:  Fan-Chi Su; Panayiotis Mavroidis; Chengyu Shi; Brigida Costa Ferreira; Niko Papanikolaou
Journal:  Comput Methods Programs Biomed       Date:  2010-03-24       Impact factor: 5.428

3.  Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes.

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

4.  On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Med Biol Eng Comput       Date:  2007-06-16       Impact factor: 2.602

5.  On the making of sharp longitudinal dose profiles with helical tomotherapy.

Authors:  Michael W Kissick; Ryan T Flynn; David C Westerly; Thomas Rockwell Mackie; Peter W Hoban
Journal:  Phys Med Biol       Date:  2007-10-16       Impact factor: 3.609

6.  A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.

Authors:  Robert F Hobbs; Sébastien Baechler; De-Xue Fu; Caroline Esaias; Martin G Pomper; Richard F Ambinder; George Sgouros
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

7.  The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies.

Authors:  M Hussein; S Aldridge; T Guerrero Urbano; A Nisbet
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

Review 8.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

9.  A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.

Authors:  M Fatyga; J F Williamson; N Dogan; D Todor; J V Siebers; R George; I Barani; M Hagan
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

10.  A genetic algorithm for variable selection in logistic regression analysis of radiotherapy treatment outcomes.

Authors:  Olivier Gayou; Shiva K Das; Su-Min Zhou; Lawrence B Marks; David S Parda; Moyed Miften
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.